Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Mar 20.
doi: 10.1038/s41590-026-02458-x. Online ahead of print.

TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size

Affiliations

TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size

Khader Ghneim et al. Nat Immunol. .

Abstract

Immune interventions toward an HIV cure have focused on rejuvenating adaptive immune responses. Herein we provide a framework that features epigenetic programming of myeloid and CD4+ T cells as a major mechanism that promotes decay of the HIV reservoir. Coordinate regulation of gene expression and chromatin accessibility of pathways of innate antiviral immunity was associated with decay of cell-associated viral DNA (CA-vDNA) following analytical treatment interruption in simian immunodeficiency virus-infected rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1. TGF-β/SMAD signaling in a subset of combo-treated CA-vDNAhi RMs, suppressed this antiviral activity through histone deacetylases, reducing chromatin accessibility of interferon regulatory factors (IRFs) and STATs. Addition of HDAC inhibitors in vitro restored antiviral response in the presence of TGF-β. Induction of IL-6 in CA-vDNAlo RMs amplified the antiviral network through IRF9. We identified an overlapping molecular cascade in HIV elite controllers, who maintain small HIV reservoirs without antiviral treatment. These data provide insights into strategies for HIV cure interventions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: G.R., E.R., C.V.P., G.W., L.M., D.M.G., B.J.H. and D.J.H. are employed by and/or have financial interests in Merck & Co. The remaining authors declare no competing interests.

Update of

References

    1. Darcis, G., Van Driessche, B. & Van Lint, C. HIV latency: should we shock or lock? Trends Immunol. 38, 217–228 (2017). - PubMed - DOI
    1. Carcelain, G. & Autran, B. Immune interventions in HIV infection. Immunol. Rev. 254, 355–371 (2013). - PubMed - DOI
    1. Rutishauser, R. L. & Trautmann, L. CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies. Curr. Opin. HIV AIDS 17, 315–324 (2022). - PubMed - PMC - DOI
    1. McBrien, J. B., Kumar, N. A. & Silvestri, G. Mechanisms of CD8(+) T cell-mediated suppression of HIV/SIV replication. Eur. J. Immunol. 48, 898–914 (2018). - PubMed - PMC - DOI
    1. van der Heijden, W. A. et al. Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells. JCI Insight 9, a022236 (2021).

LinkOut - more resources